---
$id: https://graph.org.ai/products/commodity/51323109
$type: Product
source: UNSPSC
code: "51323109"
title: "Xenyhexenic acid"
class: "51323100"
classTitle: "Antihyperlipidemics and hypocholesterolemics, synthesized"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Xenyhexenic acid

**UNSPSC Code**: 51323109
**Class**: [Antihyperlipidemics and hypocholesterolemics, synthesized](Antihyperlipidemics and hypocholesterolemics, synthesized.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-lipidemic agent with the molecular formula C18H18O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4293LHY68W, chemically known as 4-hexenoic acid, 2-(4-biphenylyl)- but generally known as xenyhexenic acid, which bears US NIH Compound Identifier 6436176. European Medicines Agency schedules Xenyhexenic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00107MIG. The term XENYHEXENIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). Most nations schedule xenyhexenic acid under HS 29163900 and SITC 51379. As of Q4 2014, XENYHEXENIC ACID remains the US FDA Preferred Term for this commodity. Xenyhexenic acid bears US NLM identifiers UMLS ID C1883576 and NCI Concept Code C66667. SMILES: OC(=O)C(c1ccc(cc1)c1ccccc1)C/C=C/C.

